[KoNECT] 해외 임상시험 정보 데이터(Global Data) 보고서 업데이트 안내 05.19(금)

Global Data Intelligence Center
구분	보고서 (영문)	업로드 날짜
제약/ 바이오/ 임상시험	Thematic Intelligence: Immuno-oncology (2023)	05-10-2023
	ImmunoGen’s Drug Elahere Offers Hope for Ovarian Cancer Patients	05-10-2023
	Ultragenyx’s Phase I/II Study for mRNA Therapeutic Terminated	05-05-2023
	Contract Manufacturing: Opportunities and Threats – April 2023	05-02-2023
	April Quarterly Contract Manufacturing Mergers, Acquisitions, and Financing – Q2 2023	05-02-2023
	Oncology Drug Sales Expected to Generate $2.2 Trillion by 2029	05-02-2023
	Contract Service Agreements – April 2023	05-02-2023
	Bio/Pharmaceutical Outsourcing Report, April 2023	04-28-2023
	A Broad Range of Unmet Needs Remains in the Immuno-Oncology Space	04-28-2023
	APAC Leads in Trials for 2022, with the Majority in Phase II	04-28-2023
	Novo Nordisk Blockbuster Ozempic Boasts 23% Sales Surge in 2023	04-28-2023
	First Allogeneic Stem Cell Therapy Approval to Pave the Way for Future Therapies in This Class	04-28-2023
질환별	Myocardial Infarction: Competitive Landscape	04-30-2023
	Melanoma: Cell & Gene Therapies 15-Market Assessment and Forecast	04-28-2023
	Ovarian Cancer: Cell & Gene Therapies 15-Market Assessment and Forecast	04-28-2023